Sandra V Navarra
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
2011/02/01 by Sandra Navarra, Sandra V Navarra, Renato M Guzmán +27 · 2 citations
Medicine · Neuroscience · #Adverse effect #Alternative medicine #Antibody #Autoimmune disease #B cell #B-cell activating factor #Belimumab #Clinical endpoint #Clinical trial #Connective tissue disease #Disease #Immunology #Internal medicine #Lupus erythematosus #Medicine #Multiple Sclerosis Research Studies #Pathology #Placebo #Randomized controlled trial #Systemic Lupus Erythematosus Research #Systemic lupus erythematosus #Vagus Nerve Stimulation Research